SCHEMBL24012307

SCHEMBL24012307

CO[C@@H]1C[C@H](C(=O)Nc2cc(N)ccc2F)N(C(=O)OC(C)(C)C)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ F10 P00742 2/20 0.43
▸ KLKB1 P03952 2/20 0.43
▸ ABL1 P00519 5/20 0.42
▸ BCR P11274 5/20 0.42
▸ LMNA P02545 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ UCHL1 P09936 1/20 0.41
▸ CFD P00746 2/20 0.38
▸ NR1H2 P55055 1/20 0.38
▸ HTRA1 Q92743 1/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC2 Q92769 1/20 0.37
▸ USP30 Q70CQ3 1/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ MCL1 Q07820 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31456830 0.85 CYP1A2 (0.46) CYP1A2POLBCYP3A4CYP2C19F10
SCHEMBL29581125 0.85 CYP1A2 (0.46) CYP1A2POLBCYP3A4CYP2C19F10
SCHEMBL20584698 0.81 KLKB1 (0.52) CYP1A2POLBCYP3A4CYP2C19F10
SCHEMBL20584700 0.81 KLKB1 (0.52) CYP1A2POLBCYP3A4CYP2C19F10
SCHEMBL29580856 0.81 KLKB1 (0.52) CYP1A2POLBCYP3A4CYP2C19F10
SCHEMBL20584697 0.81 KLKB1 (0.52) CYP1A2POLBCYP3A4CYP2C19F10
SCHEMBL20584573 0.81 KLKB1 (0.51) CYP1A2POLBCYP3A4CYP2C19F10
SCHEMBL20446447 0.81 KLKB1 (0.51) CYP1A2POLBCYP3A4CYP2C19F10
SCHEMBL20584575 0.81 KLKB1 (0.51) CYP1A2POLBCYP3A4CYP2C19F10
SCHEMBL20446602 0.81 CYP1A2 (0.43) CYP1A2POLBCYP3A4CYP2C19F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3355890-B1 HUMAN PLASMA KALLIKREIN INHIBITORS BIOCRYST PHARM INC (US) 2021-11-10 — — EP disclosed
Send feedback